Chase AIPricingFAQs
Display currency
Loading news…

Recludix Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Diego, California, United States Founded 2019 51-100 employees For Profit

Recludix pharma is a developing platform to treat cancer patients.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
45

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
33
IT spend
$1.04M

Company Info

Founded
2019
Employees
51-100
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
52
HQ
San Diego, California, United States
Region
Greater San Diego Area, West Coast, Western US
Diversity spotlight
Women Led

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
-0.5
Trend (30d)
-1.9
Trend (90d)
-1.8
Last leadership hire
Jul 14, 2025

Key People at Recludix Pharma

Co-Founder, VP of Chemistry
President and Head of Research and Development
Chief Business Officer
CEO
45
professional contacts at Recludix Pharma
Contact execs at Recludix Pharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Recludix Pharma

Loading news…

FAQs about Recludix Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.
Recludix Pharma - Company Profile, Full Acquisitions List, Funding and Investments